Promoter holding
64.27%
EI
Endolite India Limited - Due diligence report
A 360° intelligence report on Endolite India Limited: trust score, financial health, credit view, compliance, directors, growth and distress…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Endolite India Limited — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Endolite India Limited is assessed as Moderate with a Trust Score of 74/100. Endolite India Limited is an active public limited indian non-government company incorporated in 1995, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 21 Jul 2026 from the latest processed filings. Endolite India Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Elevated gearing (D/E 1.42).
Charges position: 0 open (-) · 1 satisfied (4.28 Lakh).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Unitel Credit Pvt Ltd | 1 | 48.0 cr |
Compliance Score: 80/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 3 court forum(s).
- 16 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SURINDER MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PARESH BHAGWANJI SIDPRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PAUL GRAHAM ROBERTS | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| INDER PAL SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHARAT BHUSHAN PANDE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ROHAN MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 2 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Endolite Lanka Private Limited | Subsidiary Company | 74.00% |
| Chas A. Blatchford & Sons Ltd. | Associate Company | 74.00% |
Key managerial personnel: BHARAT BHUSHAN PANDE (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 30+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Sep 2022
Director ceased
ROHAN MEHTA
29 Aug 2022
Director appointed
ROHAN MEHTA (Director)
26 Jul 2022
Director ceased
BRIAN STEPHEN BLATCHFORD
30 Mar 2022
Charge satisfied
Unitel Credit Pvt Ltd
06 Apr 2021
Director ceased
PARESH BHAGWANJI SIDPRA
Director ceased
PAUL GRAHAM ROBERTS
31 Mar 2021
Share transfer (FY 2021)
600.00000000 shares to ROHAN MEHTA
Share transfer (FY 2021)
150300.00000000 shares to SURINDER MEHTA
15 Mar 2021
Director appointed
PARESH BHAGWANJI SIDPRA (Director)
Director appointed
PAUL GRAHAM ROBERTS (Director)
22 Feb 2021
Director ceased
ADRIAN STENSON
16 Dec 2019
Director ceased
ARCHNA MEHTA
01 Dec 2019
Director ceased
BHARAT BHUSHAN PANDE
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
16 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
4 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Singhal Ventures Private Limited | U50102BR2007PTC013142 | Patna, Bihar, India |
| Foce | L33100MH2001PLC130385 | Mumbai, Maharashtra, India |
| Venti Oelde India Private Limited | U74900MH2007PTC173426 | Mumbai, Maharashtra, India |
| Thegoldentime | U52391GJ2008PTC054455 | Ahmedabad, Gujarat, India |
| Vrf Aircon Private Limited | U29192PN2008PTC131564 | Pune, Maharashtra, India |
| Staras Seating Private Limited | U51909MH2005PTC154583 | Mumbai, Maharashtra, India |
| Kabsons Industries | L23209TG1993PLC014458 | Hyderabad, Telangana, India |
| Ingex Botanicals | U74994KA2017PTC106540 | Bangalore, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Endolite India Limited before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Endolite India Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Endolite India Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Endolite India Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Endolite India Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Endolite India Limited an active company?
Endolite India Limited has MCA status “Active” with a compliance score of 80/100 (Low Risk).
Is Endolite India Limited financially healthy?
Endolite India Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Endolite India Limited?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Endolite India Limited?
Promoters hold a majority stake - exact percentages are in the full report. 6 active director(s) are on record.
Does Endolite India Limited have loans or charges against its assets?
No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Endolite India Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 80/100 (Low Risk).
Is it risky to lend to Endolite India Limited?
Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
